中医药现代化专栏

“拈痛散”膏灸联合三阶梯止痛法治疗晚期胃癌癌性疼痛的疗效及对癌因性疲乏的影响

  • 张静 ,
  • 李艳 ,
  • 丁铌 ,
  • 郭曼
展开
  • 1.青岛市中医医院、青岛大学附属青岛市海慈医院,肿瘤科,(山东 青岛 266033 )
    2.青岛市中医医院、青岛大学附属青岛市海慈医院,风湿免疫血液科,(山东 青岛 266033 )

收稿日期: 2026-01-28

  网络出版日期: 2026-05-27

基金资助

山东省中医药科技项目(Q-2022007)

Efficacy of Niantong powder plaster moxibustion combined with three-step analgesic ladder in the treatment of advanced gastric cancer with cancer pain and influence on cancer-related fatigue

  • Jing ZHANG ,
  • Yan LI ,
  • Ni DING ,
  • Man GUO
Expand
  • 1.Oncology Department,Qingdao Traditional Chinese Medicine Hospital,Qingdao Hiser Hospital Affiliated of Qingdao University,Qindgao 266033,Shandong,China
    2.Department of Rheumatology,Immunology,and Hematology,Qingdao Traditional Chinese Medicine Hospital,Qingdao Hiser Hospital Affiliated of Qingdao University,Qindgao 266033,Shandong,China

Received date: 2026-01-28

  Online published: 2026-05-27

摘要

目的 分析“拈痛散”膏灸联合三阶梯止痛法治疗晚期胃癌患者癌性疼痛的疗效及对癌因性疲乏的影响。 方法 选取青岛市中医医院2023年1月至2025年6月收治的152例晚期胃癌癌痛且存在癌因性疲乏的患者,随机分为对照组与联合组,各76例。对照组予以三阶梯止痛法,联合组予以三阶梯止痛法联合“拈痛散”膏灸治疗,连续治疗4周后评价疗效。观察两组患者的癌痛疗效、数字分级法(NRS)评分、简明疼痛评估量表(BPI)评分、Piper疲乏修订量表(PFS-R)评分、疼痛介质[5-羟色胺(5-HT)、P物质(SP)、神经肽Y(NP-Y)、前列腺素E2(PGE2)]及不良反应。 结果 治疗后,联合组的癌痛有效率较对照组更高(P < 0.05);联合组的NRS评分、BPI-疼痛程度评分、BPI-疼痛干扰评分、PFS-R评分均低于对照组(P < 0.05),血清SP、5-HT、NP-Y、PGE2水平也均低于对照组(P < 0.05)。两组不良反应发生率接近(P > 0.05)。 结论 “拈痛散”膏灸联合三阶梯止痛法治疗晚期胃癌癌痛的疗效显著,可逆转疼痛因子失衡,缓解癌因性疲乏。

本文引用格式

张静 , 李艳 , 丁铌 , 郭曼 . “拈痛散”膏灸联合三阶梯止痛法治疗晚期胃癌癌性疼痛的疗效及对癌因性疲乏的影响[J]. 实用医学杂志, 2026 , 42(10) : 1805 -1810 . DOI: 10.3969/j.issn.1006-5725.2026.10.015

Abstract

Objective To analyze the efficacy of Niantong powder plaster moxibustion combined with the three-step analgesic ladder in the treatment of cancer pain in patients with advanced gastric cancer and its influence on cancer-related fatigue. Methods A total of 152 patients with advanced gastric cancer, cancer pain, and cancer-related fatigue, who were admitted to Qingdao Traditional Chinese Medicine Hospital from January 2023 to June 2025, were selected and randomly divided into a control group and a combined group, with 76 cases in each group. The control group was treated with the three-step analgesic ladder, whereas the combined group received treatment with the three-step analgesic ladder combined with Niantong powder plaster moxibustion. The efficacy was evaluated after 4 weeks of continuous treatment. In the two groups of patients, the efficacy of cancer pain, scores of the numerical rating scale (NRS), brief pain inventory (BPI), and revised Piper fatigue scale (PFS-R), pain mediators [5-hydroxytryptamine (5-HT), substance P (SP), neuropeptide Y (NP-Y), prostaglandin E2 (PGE2)], and adverse reactions were observed. Results After treatment, the cancer pain relief rate in the combined group was significantly higher than that in the control group (P < 0.05). The combined group had lower NRS scores, BPI-pain severity scores, BPI-pain interference scores, and PFS-R scores compared to the control group (P < 0.05). Additionally, it also presented lower serum levels of SP, 5-HT, NP-Y, and PGE2 (P < 0.05). The incidence of adverse reactions was comparable between the two groups (P > 0.05). Conclusions Niantong powder plaster moxibustion, when combined with the three- step analgesic ladder, demonstrates significant efficacy in treating advanced gastric cancer accompanied by cancer pain. Moreover, it can reverse the imbalance of pain factors and alleviate cancer-related fatigue.

参考文献

[1] L?HRE E T, THRON?S M, KLEPSTAD P. Breakthrough cancer pain in 2020[J]. Curr Opin Support Palliat Care, 2020, 14(2): 94-99. doi: 10.1097/SPC.0000000000000494 .
[2] ATA F, YOUSAF Z, KALAJI B N AL, et al. Back pain as an initial feature of advanced gastric cancer mimicking multiple myeloma: A case report and literature review[J]. Qatar Med J, 2022, 2022(4): 53. doi: 10.5339/qmj.2022.53 .
[3] WANG D, JIANG T, ZHENG L, et al. Analgesic treatment for refractory cancer pain caused by gastric cancer bone metastasis: A case report and literature review[J]. Medicine (Baltimore), 2024, 103(28): e38851. doi: 10.1097/MD.0000000000038851 .
[4] TAKEI D, TAGAMI K. Management of cancer pain due to bone metastasis[J]. J Bone Miner Metab, 2023, 41(3): 327-336. doi: 10.1007/s00774-022-01382-y .
[5] BROZOVI? G, LESAR N, JANEV D, et al. CANCER PAIN AND THERAPY[J]. Acta Clin Croat, 2022, 61(): 103-108. doi: 10.20471/acc.2022.61.s2.13 .
[6] 《慢性癌性疼痛中医诊疗规范专家共识》制订专家组. 慢性癌性疼痛中医诊疗规范专家共识[J]. 江苏中医药, 2025, 57(7): 69-72. doi: 10.19844/j.cnki.1672-397X.2025.07.018 .
[7] 李壮苗,燕文娟,刘芳,等. 姜黄天灸膏穴位贴敷治疗脑卒中偏瘫肩痛临床疗效观察[J]. 中国针灸, 2023, 43(12): 1373-1378. doi: 10.13703/j.0255-2930.20230130-0001 .
[8] TAN C, WONG J F, YEE C M, et al. Methadone rotation for cancer pain: An observational study[J]. BMJ Support Palliat Care, 2022, 12(e6): e736-e739. doi: 10.1136/bmjspcare-2019-002175 .
[9] MAO J J, LIOU K T, BASER R E, et al. Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial[J]. JAMA Oncol, 2021, 7(5): 720-727. doi: 10.1001/jamaoncol.2021.0310 .
[10] 中国抗癌协会癌症康复与姑息治疗专业委员会,中国临床肿瘤学会肿瘤支持与康复治疗专家委员会. 癌症相关性疲乏诊断与治疗中国专家共识[J]. 中华医学杂志, 2022, 102(3): 180-189. doi: 10.3760/cma.j.cn112137-20210811-01789 .
[11] 李鑫,解晓芳,张光,等. 玄乌止痛膏穴位贴敷联合加味芍药甘草汤对癌性疼痛患者的疗效[J]. 辽宁中医杂志, 2024, 51(5): 164-167. doi: 10.13192/j.issn.1000-1719.2024.05.044 .
[12] MESTDAGH F, STEYAERT A, LAVAND'HOMME P. Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques[J]. Curr Oncol, 2023, 30(7): 6838-6858. doi: 10.3390/curroncol30070500 .
[13] 张馨予. 中药外敷抗癌止痛贴联合针刺三阶梯药物止痛法治疗癌症疼痛的临床研究[J]. 辽宁中医杂志, 2022, 49(2): 165-169. doi: 10.13192/j.issn.1000-1719.2022.02.046 .
[14] 魏世民,董宝强,富昱,等. 经筋刺法联合艾灸治疗阳虚型肺癌患者癌性疼痛的临床研究[J]. 辽宁中医杂志, 2020, 47(2): 169-171. doi: 10.13192/j.issn.1000-1719.2020.02.052 .
[15] THONG M S Y, VAN NOORDEN C J F, STEINDORF K, et al. Cancer-Related Fatigue: Causes and Current Treatment Options[J]. Curr Treat Options Oncol, 2020, 21(2): 17. doi: 10.1007/s11864-020-0707-5 .
[16] TANAKA K, KONDO T, NARITA M, et al. Cancer aggravation due to persistent pain signals with the increased expression of pain-related mediators in sensory neurons of tumor-bearing mice[J]. Mol Brain, 2023, 16(1): 19. doi: 10.1186/s13041-023-01001-5 .
[17] SáNCHEZ M L, RODRíGUEZ F D, COVE?AS R. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies[J]. Int J Mol Sci, 2023, 24(12): 9962. doi: 10.3390/ijms24129962 .
[18] 石明宏,刘占伟,朱洋,等. 氨酚羟考酮联合局部放疗对老年恶性肿瘤骨转移癌痛患者血清细胞因子的影响[J]. 实用医学杂志, 2025, 41(11): 1718-1723. doi: 10.3969/j.issn.1006-5725.2025.11.016 .
[19] 莫威,曾繁睿,易炜,等. "围放疗期"动态调整盐酸羟考酮缓释片剂量对肺癌骨转移患者镇痛效果的影响[J]. 实用医学杂志, 2022, 38(24): 3150-3154. doi: 10.3969/j.issn.1006-5725.2022.24.023 .
[20] LI C, CAI Q, WU X, et al. Anti-inflammatory Study on the Constituents of Angelica sinensis (Oliv.) Diels, Angelica dahurica (Hoffm.) Benth. & Hook.f. ex Franch. & Sav., Angelica pubescence Maxim and Foeniculum vulgare Mill. Essential Oils[J]. J Oleo Sci, 2022, 71(8): 1207-1219. doi: 10.5650/jos.ess22031 .
[21] HUSSAIN H, RASHAN L, HASSAN U, et al. Frankincense diterpenes as a bio-source for drug discovery[J]. Expert Opin Drug Discov, 2022, 17(5): 513-529. doi: 10.1080/17460441.2022.2044782 .
[22] PENG J, SONG X, YU W, et al. The role and mechanism of cinnamaldehyde in cancer[J]. J Food Drug Anal, 2024, 32(2): 140-154. doi: 10.38212/2224-6614.3502 .
[23] DENG J, HAN J, CHEN J, et al. Comparison of analgesic activities of aconitine in different mice pain models[J]. PLoS One, 2021, 16(4): e0249276. doi: 10.1371/journal.pone.0249276 .
[24] 张珂洋, 张永清, 杨春淼, 等. 全蝎的炮制历史沿革、化学成分及药理作用研究进展[J]. 中国中药杂志, 2024, 49(4): 868-883. doi: 10.19540/j.cnki.cjcmm.20230814.202 .
[25] 刘丽丽, 尧章洪, 李童, 等. 吴茱萸现代药理作用、剂型设计与临床外用研究进展[J]. 中华中医药学刊, 2025, 43(6): 52-60. doi: 10.13193/j.issn.1673-7717.2025.06.009 .
文章导航

/